GlassScriptPhysician profile
Brianna Edson
NPI 1003448846
$501.83
in general payments reported to CMS, 2019-2025
11 companies · $33.41 in 2025
The $33.41 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.14 · 2022: $57.95 · 2023: $182 · 2024: $208 · 2025: $33.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.85 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $137.80 | 2023-2024 | |
| Lilly USA, LLC | $68.45 | 2022-2024 | Jardiance, Zepbound, Emgality |
| Novo Nordisk INC | $61.51 | 2022-2024 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $39.41 | 2023-2024 | |
| Exact Sciences Corporation | $38.26 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $34.55 | 2024-2025 | Evenity, Prolia |
| Glaxosmithkline, LLC. | $33.13 | 2022-2024 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.58 | 2023 | Spiriva Respimat, Stiolto Respimat |
| Sanofi-Aventis U.S. LLC | $21.14 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $21.03 | 2024 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $16.97 | 2024 | Airsupra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brianna Edson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.